
Results
327
Companies which are more than 50% undervalued based on analyst price target.
327 companies
Rakovina Therapeutics
Market Cap: CA$2.9m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.14
7D
-22.9%
1Y
-83.1%
District Copper
Market Cap: CA$2.2m
Engages in the acquisition and exploration of mineral properties in Canada.
DCOP
CA$0.065
7D
0%
1Y
44.4%
FluroTech
Market Cap: CA$1.7m
Focuses on the commercialization of fluorescence spectroscopy technology to test for COVID-19.
TEST.H
CA$0.075
7D
0%
1Y
n/a